— Know what they know.
Not Investment Advice

DMAAR NASDAQ

Drugs Made In America Acquisition Corp. Rights
1W: +2.0% 1M: -1.9% 3M: +15.9% YTD: -28.4% 1Y: -41.5%
$0.13
+0.00 (+0.87%)
 
Weekly Expected Move ±21.1%
$0 $0 $0 $0 $0
NASDAQ · Financial Services · Shell Companies · Tech Score Neutral · Power 46 · $287.8M mcap · 19M float · 0.262% daily turnover · Short 37% of daily vol

ESG Scores — DMAAR

Company vs Sector Average

Historical ESG Trend

View All ESG Filings (4)
Date Form Environmental Social Governance ESG Score Filing
2026-06-30 10-Q 58.5 78.8 73.8 70.4 SEC ↗
2026-03-31 10-Q 58.5 80.6 74.3 71.1 SEC ↗
2025-12-31 10-K 74.1 76.1 70.0 73.4 SEC ↗
2025-09-30 10-Q 61.1 83.1 70.8 71.6 SEC ↗

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms